160 related articles for article (PubMed ID: 37272203)
1. Effects and mechanisms of trifluridine alone or in combination with cryptotanshinone in inhibiting malignant biological behavior of gastric cancer.
Luo PQ; Zhang LX; Chen ZM; Wang G; Zhu H; Ying S; Wei ZJ; Han WX; Xu AM
Cell Cycle; 2023 Jun; 22(12):1463-1477. PubMed ID: 37272203
[TBL] [Abstract][Full Text] [Related]
2. Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation.
Lu L; Zhang S; Li C; Zhou C; Li D; Liu P; Huang M; Shen X
Cell Death Dis; 2017 May; 8(5):e2767. PubMed ID: 28492557
[TBL] [Abstract][Full Text] [Related]
3. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
4. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
6. Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.
Baba Y; Tamura T; Satoh Y; Gotou M; Sawada H; Ebara S; Shibuya K; Soeda J; Nakamura K
Mol Oncol; 2017 Aug; 11(8):1065-1077. PubMed ID: 28486761
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
[TBL] [Abstract][Full Text] [Related]
8. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
9. An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA.
Emura T; Nakagawa F; Fujioka A; Ohshimo H; Yokogawa T; Okabe H; Kitazato K
Int J Mol Med; 2004 Feb; 13(2):249-55. PubMed ID: 14719131
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
Cao Y; Wang J; Tian H; Fu GH
J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
[TBL] [Abstract][Full Text] [Related]
11. Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway.
Bei Y; Chen X; Xu Q; Lv J; Hu J; Yang S
Drug Dev Res; 2022 Apr; 83(2):379-388. PubMed ID: 34405891
[TBL] [Abstract][Full Text] [Related]
12. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
Tanaka N; Sakamoto K; Okabe H; Fujioka A; Yamamura K; Nakagawa F; Nagase H; Yokogawa T; Oguchi K; Ishida K; Osada A; Kazuno H; Yamada Y; Matsuo K
Oncol Rep; 2014 Dec; 32(6):2319-26. PubMed ID: 25230742
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of isocryptotanshinone on gastric cancer.
Chen ZM; Huang L; Li MM; Meng L; Ying SC; Xu AM
Sci Rep; 2018 Jun; 8(1):9307. PubMed ID: 29915371
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
Wang J; Zhang G; Dai C; Gao X; Wu J; Shen L; Chen Z; Liu P
J Int Med Res; 2017 Feb; 45(1):220-230. PubMed ID: 28222632
[TBL] [Abstract][Full Text] [Related]
15. Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.
Fujimoto Y; Nakanishi R; Nukatsuka M; Matsuoka K; Ando K; Wakasa T; Kitao H; Oki E; Maehara Y; Mori M
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1029-1038. PubMed ID: 32322913
[TBL] [Abstract][Full Text] [Related]
16. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
[TBL] [Abstract][Full Text] [Related]
17. Receptor-interacting protein-1 promotes the growth and invasion in gastric cancer.
Zhu G; Ye J; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J
Int J Oncol; 2016 Jun; 48(6):2387-98. PubMed ID: 27035122
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma.
Chen Z; Zhu R; Zheng J; Chen C; Huang C; Ma J; Xu C; Zhai W; Zheng J
Oncotarget; 2017 Jul; 8(30):50023-50033. PubMed ID: 28654902
[TBL] [Abstract][Full Text] [Related]
19. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling.
Lu L; Li C; Li D; Wang Y; Zhou C; Shao W; Peng J; You Y; Zhang X; Shen X
Mol Cell Biochem; 2013 Sep; 381(1-2):273-82. PubMed ID: 23740516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]